ArticleExperimental and therapeutic medicine2022
Occurrence of hyperprogressive disease following administration of immune checkpoint inhibitors in lung squamous cell carcinoma: A case report.
Shixia Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.